Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL

• Main Authors: Munir, T, Cohen, D, Milligan, D, Schuh, A, McParland, L, Chalmers, A, Varghese, A, Rawstron, A, Allsup, D, Marshall, S, Smith, A, Collett, C, Gregory, W, Duncombe, A, Hillmen, P
• Format: Article in Journal/Newspaper
• Language: unknown
• Published: 2016
• Subjects: Arctic
• Online Access: https://ora.ox.ac.uk/objects/uuid:2ab60540-bb4d-44e0-830b-8a1d33e68e6c